Virology Market is estimated to be US$ 4.89 billion by 2030 and is anticipated to register a CAGR of 9.9%.

Virology is study of viruses including submicroscopic, parasitic particles of genetic material contained in a protein coat, and virus-like agents. Virology is concentrated on distribution, biochemistry, physiology, ecology, evolution, molecular biology, and clinical aspects of viruses. Viruses are responsible for controlled or developed diseases. Viruses have beneficial properties that can be used in gene therapy or vaccinology. According to data published by Institute of Human Virology (IHV), IHV has a unique HIV/AIDS vaccine which is designed to neutralize many different strains of HIV found across the globe. Virology starts when there was no procedure for propagating or visualizing viruses or specific laboratory tests for viral infection. The methods for separating viral nucleic acids (RNA & DNA) and proteins, which are now the mainstay of virology, did not exist. Thousand of different viruses are now known about virologists often specialize in either the viruses that infect plants, or bacteria and other microorganisms, or animals. Virologists are scientists who examine, study, and explore viruses and viral diseases. Moreover, they are responsible for studying the growth, development, characteristics, and structure of various viruses. The global virology market accounted for US$ 1.92 billion in 2020 and is estimated to be US$ 4.89 billion by 2030 and is anticipated to register a CAGR of 9.9%.

The report "Virology Market, By Product Type (DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests), By Viral Infection Controlling Method (Immunoprophylaxis, Active Prophylaxis, Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, and Immunomodulators), and Interferons), By Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, and Perinatal Infections), By End-User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Trends, Analysis and Forecast till 2030"

Key Market Insights from the report:          

The global virology market accounted for US$ 1.9 billion in 2020 and is projected to register a moderate CAGR of 9.9% over the forecast period. The market report has been segmented on the basis of product type, viral infection controlling method, application, end-user, and region.

  • By product type, the global virology market is categorized into DNA viruses, RNA viruses, prions diagnostic test, and other viral tests
  • By viral infection controlling method, Immunoprophylaxis therapy and antiviral drugs segments are accounted for fastest growing segment in the global virology market.
  • By application, urinary tract infections, and respiratory tract infections application segment is dominated in the global virology market.
  • By end-user, the hospitals and laboratories segment is accounted for major revenue share in the global virology market.
  • By region, North America virology market is expected to account for largest share in terms of revenue in the global virology market over the forecast period. This is attributed to technological advancements such as the increasing rapid and portable diagnostics in countries such as U.S. of the region. Europe virology market is expected to account for second-highest share in terms of revenue in the global virology market in the near future.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/743

The key players operating in the virology market includes GlaxoSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck KGaA, Novartis International AG, Siemens AG, Johnson & Johnson, AstraZeneca AB, Roche Holding AG, and Abivax SA. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global virology market.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

+1 860 531 2701

Email- sales@prophecymarketinsights.com

Website:www.prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Global Platelet Rich Plasma Market is estimated to be US$ 1003.06 million by 2030 with a CAGR of 11.50% during the forecast period.

Image
Global Platelet Rich Plasma Market accounted for US$ 337.23 million in 2020 and is estimated to be US$ 1003.06 million by 2030 and is anticipated to register a CAGR of 11.50%. Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is created by extracting red blood cells from blood. When the concentration of platelets in human blood is reduced, platelet-rich plasma is separated, which contains a concentration of platelets above typical values. Platelets thicken the blood and aid in the repair of muscles, ligaments, and tendons. They are extremely high in healing and connective tissue development factors. Platelet-rich plasma (PRP) blends the body's natural ability to heal itself with modern technologies. It has a wide range of medical applications, including neurology, orthopaedics, and ophthalmology. It's also employed in procedures like tendon repair and rotator cuff augmentation. The report   " Global Platelet Rich Plasma Market, By Type (Pure Platelet...
Read more

Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market

Image
Neurodegenerative Disorder Therapeutics Market   accounted for US$ 9.32 billion in 2019 and is estimated to be US$ 21.3 billion by 2029 and is anticipated to register a CAGR of 8.7% The report " Global  Neurodegenerative Disorder Therapeutics Market, By  Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, and Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In November 2019, Alkermes plc and Rodin Therapeutics, Inc. announced that they have entered into a definitive agreement under which Alkermes will acquire Rodin, a privately held biopharmaceutical company focused ...
Read more

Systemic Lupus Erythematosus Market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%

Image
  Systemic Lupus Erythematosus (SLE) is the chronic, autoimmune disorder which involves several organ-systems such as kidney, heart, blood, skin, joints, and lungs in most severe cases, brain. In this disease, the human immune system converts hyperactive and attacks the healthy, normal tissues of the body. SLE can often result in symptoms such as malar rash, sub-acute cutaneous lesions, discoid lesions, arthritis, photosensitivity, oral ulcers, serositis, nephropathy, thrombocytopenia, haemolytic anemia, neurologic involvement, fever, thrombosis, Raynaud’s phenomenon, livedo reticularis, and myositis. The global systemic lupus erythematosus market accounted for US$ 1.87 billion in 2019 and is estimated to be US$ 3.6 billion by 2029 and is anticipated to register a CAGR of 7.0%. The report  " Global   Systemic Lupus Erythematosus Market, By Drug Classes (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, and Biologics), By Route of Administration (Oral, In...
Read more